Pathology of idiopathic pulmonary fibrosis with particular focus on vascular endothelium and epithelial injury and their therapeutic potential

W Lu, A Teoh, M Waters, G Haug, I Shakeel… - Pharmacology & …, 2024 - Elsevier
Idiopathic pulmonary fibrosis (IPF) remains a challenging disease with no drugs available to
change the trajectory. It is a condition associated with excessive and highly progressive …

[HTML][HTML] Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis

K Li, X Liu, R Lu, P Zhao, Y Tian, J Li - Ecotoxicology and Environmental …, 2025 - Elsevier
The increasing use of anticancer drugs has led to the emergence of environmental
contaminants such as bleomycin (BLM), which poses significant threats to both aquatic …

Chlorogenic Acid Alleviates Inflammation and Fibrosis in a Murine Model of Bleomycin-Induced Systemic Sclerosis: A Histological Analysis.

JM Velázquez-Enríquez… - Future …, 2024 - search.ebscohost.com
Abstract Background/Objectives: Systemic sclerosis (SSc) is a chronic autoimmune disease
characterized by cutaneous and visceral fibrosis, vascular alterations, and a persistent …